InsiderClue
Insiders · Profile

Greenleaf Peter

Director at Pelthos Therapeutics · Chief Executive Officer at Aurinia Pharmaceuticals · Chief Executive Officer at Avalo Therapeutics. Filing since 18 May 2018. CIK 0001363683

PTHS Pelthos Therapeutics Inc. Director · 3 trades AUPH Aurinia Pharmaceuticals Inc. Chief Executive Officer · 6 trades AVTX Avalo Therapeutics, Inc. Chief Executive Officer · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
PTHS Pelthos Therapeutics Inc.
2 Oct 2026
Director
Sold on a plan
797
$16.87K
3.3%
PTHS Pelthos Therapeutics Inc.
2 Jul 2026
Director
Sold on a plan
797
$20.83K
3.2%
PTHS Pelthos Therapeutics Inc.
2 Apr 2026
Director
Sold on a plan
797
$16.67K
3.1%
AUPH Aurinia Pharmaceuticals Inc.
4 Mar 2025
Chief Executive Officer
Sold at will
164,947
$1.31M
8.4%
AUPH Aurinia Pharmaceuticals Inc.
3 Mar 2025
Chief Executive Officer
Sold at will
195,593
$1.56M
9.1%
AUPH Aurinia Pharmaceuticals Inc.
6 Mar 2024
Chief Executive Officer
Sold at will
126,981
$711.09K
7.7%
AUPH Aurinia Pharmaceuticals Inc.
2 Mar 2023
Chief Executive Officer
Sold, plan not stated
32,750
$292.79K
3.2%
AUPH Aurinia Pharmaceuticals Inc.
2 Mar 2022
Chief Executive Officer
Sold, plan not stated
9,068
$108.91K
21.6%
AUPH Aurinia Pharmaceuticals Inc.
11 May 2021
Chief Executive Officer
Bought
5,125
$54.89K
61.5%
AVTX Avalo Therapeutics, Inc.
18 May 2018
Chief Executive Officer
Bought
12,500
$49.75K
3.1%
10 decisions on file.